AI models need more data about biology, and OpenAI is paying to create it

The story
Last year, the clinical trial policy analyst Ruxandra Teslo posted an idea for super-charging medical AI systems: use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing strategies, and safety data—information usually kept hidden as valuable trade secrets. She called these…
How other outlets covered this
Compare allAlto found this story at 5 outlets. Same event, different framing — compare the headlines.
- MIT Technology ReviewAI models need more data about biology, and OpenAI is paying to create itabout 1 hour ago
- Axios"Welcome to the AGI era," OpenAI says as GPT-6 Astra debuts12 days ago
- The VergeWelcome to the AI crisis in math26 days ago
- VentureBeatWriter says its new Palmyra X6 model cuts AI agent costs by 52% as token spending surgesabout 1 month ago
- ZeroHedgeThe Marxist In The Machine4 months ago
How this story developed
Full timelineAlto has tracked this across 14 days of coverage from 5 outlets.
- AI models need more data about biology, and OpenAI is paying to create itYou are here
Powered by Gab AI
The Story At A Glance
Reading this article now — analysis appears below
💡 AI analysis provides alternative perspectives on current events